vimarsana.com
Home
Live Updates
Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection : comparemela.com
Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Related Keywords
California ,
United States ,
Rock Springs ,
South San Francisco ,
Mike Nolan ,
Ellen Hukkelhoven ,
Peter Kolchinsky ,
Prnewswire Freenome ,
Kaiser Permanente ,
Bain Capital Life Sciences ,
Research Company ,
Life Sciences Growth Fund ,
American Cancer Society Brightedge Ventures ,
Novartis ,
Eventide Asset Management ,
T Rowe Price Associates Inc ,
Freenome Holdings Inc ,
United States Preventive Services Task Force ,
Roche Venture Fund ,
Perceptive Advisors ,
American Cancer Society ,
Brightedge Ventures ,
Artis Ventures ,
Catalio Capital Management ,
Cormorant Capital ,
Farallon Capital Management ,
Fidelity Management ,
Janus Henderson Investors ,
Polaris Partners ,
Ridgeback Capital Management ,
Rock Springs Capital ,
Sands Capital ,
Soleus Capital Management ,
Price Associates ,
Arrowmark Partners ,
Byers Capital ,
Intermountain Ventures ,
Logos Capital ,
Pura Vida Investments ,
Suvretta Capital Management ,
Colorectal Cancer Screening Test Use ,
Mortal Wkly Rep ,
States Preventive Services Task Force ,
Science ,
Business ,
Health ,
Pr Newswire ,
Philanthropy ,
Cancer ,
comparemela.com © 2020. All Rights Reserved.